An alternative synthesis of the breast cancer drug fulvestrant (Faslodexs): catalyst control over C–C bond formation
Fulvestrant (Faslodex®) was synthesized in four steps (35% overall yield) from 6-dehydronandrolone acetate. Catalyst controlled, room temperature, diastereoselective 1,6-addition of the zirconocene derived from commercially available 9-bromonon-1-ene was used in the key C–C bond forming step.
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Published: |
Royal Society of Chemistry
2015
|
| Subjects: |